tech
FDA Drops Complaint Against Whoop’s Blood Pressure Tracking Tool
The US Food and Drug Administration dropped its complaint against fitness tracker brand Whoop Inc. over its blood-pressure tracking tool, marking an about-face after the agency initially asked the company to disable it.
Read full story on Bloomberg Tech → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Tech alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop